111 related articles for article (PubMed ID: 25998519)
21. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
22. Subgroup analysis based on prognostic and predictive gene signatures for adjuvant chemotherapy in early-stage non-small-cell lung cancer patients.
Moon H; Zhao Y; Pluta D; Ahn H
J Biopharm Stat; 2018; 28(4):750-762. PubMed ID: 29157115
[TBL] [Abstract][Full Text] [Related]
23. Time to adjuvant chemotherapy and survival in non-small cell lung cancer: a population-based study.
Booth CM; Shepherd FA; Peng Y; Darling G; Li G; Kong W; Biagi JJ; Mackillop WJ
Cancer; 2013 Mar; 119(6):1243-50. PubMed ID: 23131995
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy for non-small cell lung cancer: practice patterns and outcomes in the general population of Ontario, Canada.
Booth CM; Shepherd FA; Peng Y; Darling G; Li G; Kong W; Mackillop WJ
J Thorac Oncol; 2012 Mar; 7(3):559-66. PubMed ID: 22307012
[TBL] [Abstract][Full Text] [Related]
25. Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.
Ganti AK; Williams CD; Gajra A; Kelley MJ
Cancer; 2015 Aug; 121(15):2578-85. PubMed ID: 25873330
[TBL] [Abstract][Full Text] [Related]
26. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
29. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S
J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366
[TBL] [Abstract][Full Text] [Related]
30. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract][Full Text] [Related]
31. A four-gene signature from NCI-60 cell line for survival prediction in non-small cell lung cancer.
Hsu YC; Yuan S; Chen HY; Yu SL; Liu CH; Hsu PY; Wu G; Lin CH; Chang GC; Li KC; Yang PC
Clin Cancer Res; 2009 Dec; 15(23):7309-15. PubMed ID: 19920108
[TBL] [Abstract][Full Text] [Related]
32. An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer.
Lim SB; Tan SJ; Lim WT; Lim CT
Nat Commun; 2017 Nov; 8(1):1734. PubMed ID: 29170406
[TBL] [Abstract][Full Text] [Related]
33. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
[TBL] [Abstract][Full Text] [Related]
34. LncRNA HMlincRNA717 is down-regulated in non-small cell lung cancer and associated with poor prognosis.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2014; 7(12):8881-6. PubMed ID: 25674259
[TBL] [Abstract][Full Text] [Related]
35. Gene identification for risk of relapse in stage I lung adenocarcinoma patients: a combined methodology of gene expression profiling and computational gene network analysis.
Ludovini V; Bianconi F; Siggillino A; Piobbico D; Vannucci J; Metro G; Chiari R; Bellezza G; Puma F; Della Fazia MA; Servillo G; Crinò L
Oncotarget; 2016 May; 7(21):30561-74. PubMed ID: 27081700
[TBL] [Abstract][Full Text] [Related]
36. An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer.
Shahid M; Choi TG; Nguyen MN; Matondo A; Jo YH; Yoo JY; Nguyen NN; Yun HR; Kim J; Akter S; Kang I; Ha J; Maeng CH; Kim SY; Lee JS; Kim J; Kim SS
Oncotarget; 2016 Dec; 7(52):86561-86572. PubMed ID: 27863408
[TBL] [Abstract][Full Text] [Related]
37. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
39. [ERCC1 expression and outcomes of neo-adjuvant chemotherapy in elderly patients with non-small cell lung cancer].
Li GF; Deng SJ; Weng WW; Guo G; Chen N
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Sep; 30(9):2131-3. PubMed ID: 20855270
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
